ENDONOVO THERAPEUTICS, INC. (ENDV) › Operating IncomeENDONOVO THERAPEUTICS, INC. (ENDV) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$78.0K2011: -$95.5K2012: -$1.74M2013: -$2.43M2014: -$2.19M2015: -$2.56M2016: -$5.41M2017: -$4.60M2018: -$4.16M2019: -$3.81M2020: -$2.91M2021: -$2.23M2022: -$3.26M-$3.26M2010Operating Income (USD)2022Fiscal YearOperating IncomeChange YoY2022-$3.26M-46.6%2021-$2.23M+23.5%2020-$2.91M+23.5%2019-$3.81M+8.4%2018-$4.16M+9.7%2017-$4.60M+14.9%2016-$5.41M-111.0%2015-$2.56M-17.0%2014-$2.19M+9.8%2013-$2.43M-39.4%2012-$1.74M-1724.0%2011-$95.5K-22.5%2010-$78.0K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share